Success Metrics

Clinical Success Rate

94.4%

Based on 34 completed trials

Completion Rate

94%(34/36)

Active Trials

3(4%)

Results Posted

26%(9 trials)

Terminated

2(3%)

Phase Distribution

Ph phase_1

Ph phase_2

10%

Ph phase_4

14%

Ph not_applicable

64%

Ph early_phase_1

Ph phase_3

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution71 total trials

Early Phase 1First-in-human

2(2.8%)

Phase 1Safety & dosage

3(4.2%)

Phase 2Efficacy & side effects

7(9.9%)

Phase 3Large-scale testing

3(4.2%)

Phase 4Post-market surveillance

10(14.1%)

N/ANon-phased studies

46(64.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

82.9%

34 of 41 finished

Non-Completion Rate

17.1%

7 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(21)

Completed(34)

Terminated(7)

Other(10)

Detailed Status

Completed34

Not yet recruiting18

unknown10

Withdrawn5

Recruiting3

Terminated2

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

94.4%

Most Advanced

Phase 4

Trials by Phase

Early Phase 12 (2.8%)

Phase 13 (4.2%)

Phase 27 (9.9%)

Phase 33 (4.2%)

Phase 410 (14.1%)

N/A46 (64.8%)

Trials by Status

terminated23%

not_yet_recruiting1825%

completed3447%

recruiting34%

unknown1014%

withdrawn57%

Recent Activity

3 active trials

Showing 5 of 72

completednot_applicable

Stellate Ganglion Block in Bulbar Palsy

NCT06319534

not_yet_recruitingphase_2

IA Lidocaine and Methylprednisolone for Headache Associated With Subarachnoid Hemorrhage

NCT07054801

completedphase_4

Clinical Trials (72)

Showing 20 of 72 trialsScroll for more

NCT06319534Not Applicable

Stellate Ganglion Block in Bulbar Palsy

Completed

NCT07054801Phase 2

IA Lidocaine and Methylprednisolone for Headache Associated With Subarachnoid Hemorrhage

Not Yet Recruiting

NCT03854344Phase 4

Liposomal Bupivacaine Versus Lidocaine for Skin Graft Donor Site Pain

Completed

NCT06122324Not Applicable

Effect of Lidocaine on Hemodynamic Response and Postoperative Sore Throat

Completed

NCT06662318Not Applicable

Perioperative Pain Management for Lumbar Spine Surgery

Completed

NCT07205757Phase 4

Adding Lidocaine to Custodiol Mixture

Recruiting

NCT06462781Phase 1

Localized Injection of Lidocaine and Glucocorticoid for Headache Treatment Phase 1

Completed

NCT05670236Phase 4

Effect of Knee Pain on Walking Biomechanics

Completed

NCT07079449Not Applicable

Comparison of Lidocaine, Mepivacaine, and Dry Needling in Myofascial Pain Syndrome

Completed

NCT04524130Phase 4

Intraoperative Lidocaine and Combined With Ketamine on Opioid After Bariatric Surgery

Completed

NCT04048278Early Phase 1

Lidocaine Infusion in Pancreatic Cancer

Recruiting

NCT06226415Not Applicable

Exploration of Stellate Ganglion Block in Patients With Cerebral Small Vessel Disease

Completed

NCT06370195Not Applicable

Effect of Stellate Ganglion Block on Drooling in Parkinson's Syndrome

Not Yet Recruiting

NCT06347250Not Applicable

A Nerve Block Therapy for Bulbar Palsy Pharyngeal Dysphagia

Completed

NCT06335316Not Applicable

Effect of Stellate Nerve Block in Dysphagia

Completed

NCT06328998Not Applicable

Intra-articular Injection Versus Normal Rehabilitation Therapy on Temporomandibular Joint Dysfunction

Not Yet Recruiting

NCT06301737Not Applicable

Lidocaine Injection: A Nove Block Therapy for Stroke-related Dysphagia

Completed

NCT06328205Not Applicable

Impact of Glossopharyngeal Nerve Block on Swallowing Difficulties Caused by Gastroesophageal Reflux Disease

Not Yet Recruiting

NCT06319612Not Applicable

Effectiveness of Stellate Ganglion Block for the Treatment of Obstructive Sleep Apnea

Not Yet Recruiting

NCT06319521Not Applicable

Stellate Ganglion Block on Gastroesophageal Reflux Disease

Not Yet Recruiting

Drug Details

Intervention Type: DRUG
Total Trials: 72